Board/Management Information • Sep 27, 2013
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 0929P
Allergy Therapeutics PLC
27 September 2013
27 September 2013
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Change of Adviser
Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, is pleased to announce the appointment, with immediate effect, of Peel Hunt LLP as its Nominated Adviser and Broker.
-Ends-
For further information
| Allergy Therapeutics | +44 (0) 1903 845 820 |
| Manuel Llobet, Chief Executive Officer Ian Postlethwaite Finance Director |
|
| Peel Hunt LLP | +44 (0) 20 7418 8900 |
| James Steel/Dr Vijay Barathan |
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPFMGZLNNZGFZG
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.